0001636651-17-000001.txt : 20170120 0001636651-17-000001.hdr.sgml : 20170120 20170120135837 ACCESSION NUMBER: 0001636651-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170120 DATE AS OF CHANGE: 20170120 EFFECTIVENESS DATE: 20170120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-278877 FILM NUMBER: 17538261 BUSINESS ADDRESS: STREET 1: 205 EAST 42ND STREET STREET 2: SUITE 15-048 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 205 EAST 42ND STREET STREET 2: SUITE 15-048 CITY: NEW YORK STATE: NY ZIP: 10017 D 1 primary_doc.xml X0707 D LIVE 0001636651 Ovid Therapeutics Inc. 1460 Broadway Suite 15021 New York NY NEW YORK 10036 646-661-7661 DELAWARE None None Corporation true 2014 Matthew J. During 1460 Broadway Suite 15021 New York NY NEW YORK 10036 Executive Officer Director Jeremy M. Levin 1460 Broadway Suite 15021 New York NY NEW YORK 10036 Executive Officer Director Yaron Werber 1460 Broadway Suite 15021 New York NY NEW YORK 10036 Executive Officer Bart Friedman 1460 Broadway Suite 15021 New York NY NEW YORK 10036 Director Douglas E. Williams 1460 Broadway Suite 15021 New York NY NEW YORK 10036 Director Karen Bernstein 1460 Broadway Suite 15021 New York NY NEW YORK 10036 Director Amit Rakhit 1460 Broadway Suite 15021 New York NY NEW YORK 10036 Executive Officer Other Health Care Decline to Disclose 06b false 2017-01-06 false true false 0 25861228 25861228 0 false 1 0 0 0 false Ovid Therapeutics Inc. /s/Yaron Werber Yaron Werber Chief Business & Financial Officer 2017-01-18